Harmaline improves diabetes-associated renal alterations in nicotinamide/streptozotocin-induced diabetic mice: Possible involvement of oxidative stress, inflammation, and renin–angiotensin system signaling

سال انتشار: 1405
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 20

فایل این مقاله در 11 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-29-11_012

تاریخ نمایه سازی: 22 آبان 1405

چکیده مقاله:

Objective(s): Diabetic nephropathy (DN) is marked by structural and functional kidney damage, driven by oxidative stress, inflammation, and renin–angiotensin system (RAS) dysregulation. Harmaline (HAR), a β-carboline alkaloid with potent antioxidant and anti-inflammatory properties, is a promising multi-target therapeutic candidate.Materials and Methods: Twenty-four male mice were randomized into vehicle control (CO), diabetic (DI; nicotinamide ۱۲۰ mg/kg+streptozotocin ۶۵ mg/kg), diabetic treated with HAR (DI/HAR; ۳۰ mg/kg), or diabetic treated with metformin (DI/MET; ۱۵۰ mg/kg). After ten days, renal tissues and blood were analyzed for oxidative stress, inflammatory and RAS markers, microRNA expression, and histopathological alterations.Results: Harmaline reversed the changes in total oxidant status and malondialdehyde levels in kidney tissue of diabetic mice. Histopathological analysis showed significant improvement in kidney injury in diabetic mice receiving harmaline. Harmaline treatment decreased the expression of miR-۱۲۵b, nuclear factor kappa B (NF-κB), tumor necrosis factor alpha (TNF-α), interleukin-۱ beta (IL-۱β), and interleukin-۶ (IL-۶). Also, in the antioxidant pathway, there was an increase in the levels of miR-۲۰۰a, nuclear factor erythroid-related۲ (Nrf۲), and NAD(P)H quinone dehydrogenase ۱ (Nqo۱), and a decrease in ECH-like chelate-associated protein۱ (Keap۱) in kidney tissue. This treatment also decreased the expression of angiotensin-converting enzyme ۱ (ACE۱) and angiotensin II receptor ۱ (AT۱R), as well as angiotensin II levels. Conclusion: Harmaline confers renoprotection in experimental DN by simultaneously regulating oxidative stress, inflammatory signaling, and RAS pathways, supporting its potential as a multi-target therapeutic strategy. This study highlights HAR as a promising candidate for translational intervention in diabetic kidney disease.

کلیدواژه ها:

Diabetic nephropathy ، Harmaline ، Inflammation ، microRNAs ، NF-kappa B ، Nuclear factor E۲-related factor ۲ ، Oxidative stress

نویسندگان

- -

Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

- -

Diabetes Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

- -

Persian Gulf Physiology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

- -

Persian Gulf Physiology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

- -

Persian Gulf Physiology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

- -

Cellular and Molecular Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Chyła G, Sałaga-Zaleska K, Dąbkowski K, Kuchta A, Jankowski M. ...
  • Chen J, Zhang Q, Guo J, Gu D, Liu J, ...
  • Jin Q, Liu T, Qiao Y, Liu D, Yang L, ...
  • Hammad M, Raftari M, Cesário R, Salma R, Godoy P, ...
  • Suzuki T, Takahashi J, Yamamoto M. Molecular basis of the ...
  • Villeneuve NF, Lau A, Zhang DD. Regulation of the Nrf۲–Keap۱ ...
  • Chen F, Xiao M, Hu S, Wang M. Keap۱-Nrf۲ pathway: ...
  • Tossetta G, Fantone S, Piani F, Crescimanno C, Ciavattini A, ...
  • Li Y-B, Fu Q, Guo M, Du Y, Chen Y, ...
  • Yan J, Gu Q, Li J, Zhou Z, Jiang W, ...
  • Syed RU, Moni SS, Hussein W, Alhaidan TMS, Abumilha SMY, ...
  • Shen J, Dai Z, Li Y, Zhu H, Zhao L. ...
  • Karimi F, Maleki M, Movahedpour A, Alizadeh M, Kharazinejad E, ...
  • Sanglard A, Miranda BCB, Vieira ALF, Macedo MVM, Santos RL, ...
  • Yuan Q, Tang B, Zhang C. Signaling pathways of chronic ...
  • Chaubey S, Singh L. Harmaline attenuates pain and inflammation: role ...
  • Li S-P, Wang Y-W, Qi S-L, Zhang Y-P, Deng G, ...
  • Senhaji S, Lamchouri F, Akabli T, Toufik H. In vitro ...
  • Elamin N, Fadlalla I, Omer S, Ibrahim H. Histopathological alteration ...
  • Rashidi M, Mahmoudian E, Mirzaei S, Mazloomi SN, Bazi A, ...
  • Chanu KD, Sharma N, Kshetrimayum V, Chaudhary SK, Ghosh S, ...
  • Mahmoud HM, Abdel‐Razik ARH, Elrehany MA, Othman EM, Bekhit AA. ...
  • Khairani AC, Wijayanti T, Widodo GP. Antihyperglycemic activity of red ...
  • Noei Razliqi R, Ahangarpour A, Mard SA, Khorsandi L. Gentisic ...
  • Huang Y, Liu W, Liu J, Guo D, Zhang P, ...
  • Franken GA, Adella A, Bindels RJ, de Baaij JH. Mechanisms ...
  • Hu G, Jousilahti P, Peltonen M, Lindström J, Tuomilehto J. ...
  • Palmer BF, Clegg DJ. Electrolyte and acid–base disturbances in patients ...
  • Apperloo EM, Tuttle KR, Pavo I, Haupt A, Taylor R, ...
  • Mahboob S. Electrolytes and Na-K-ATPase: Potential risk factors for the ...
  • Zhou L, Yu J, Cai X, Zhu Y, Li M, ...
  • Wang L, Wang H-l, Lan H-y. TGF-β signaling in diabetic ...
  • Olatunde A, Saravanan K, Ogunro OB, Obidola MS, Jakwa A, ...
  • Wang H-Q, Wang S-S, Chiufai K, Wang Q, Cheng X-L. ...
  • Xu G-K, Sun C-Y, Qin X-Y, Han Y, Li Y, ...
  • Sas KM, Lin J, Wang C-H, Zhang H, Saha J, ...
  • Atwa AM, Abd El-Ghafar OA, Hassanein EH, Mahdi SE, Sayed ...
  • Chen C-M, Juan S-H, Chou H-C. Hyperglycemia activates the renin-angiotensin ...
  • Jiang M, Yang Z, Lyu L, Shi M. Dapagliflozin attenuates ...
  • Naaman SC, Bakris GL. Diabetic nephropathy: Update on pillars of ...
  • Li M, Popovic Z, Chu C, Reichetzeder C, Pommer W, ...
  • Paeng J, Park J, Um JE, Nam BY, Kang H-Y, ...
  • Zhang Q, Yu K, Cao Y, Luo Y, Liu Y, ...
  • Huang Y-F, Zhang Y, Liu C-X, Huang J, Ding G-H. ...
  • Hussein SM, Khodir SA, Amer GS, Abd El-aziz N, Abu-zeid ...
  • Lei L, Zhao J, Liu X-Q, Chen J, Qi X-M, ...
  • Feng Q, Yu X, Xie J, Liu F, Zhang X, ...
  • Wang Y, Wang Q, Wang M, Wang X, Liu Q, ...
  • Wang H, Li J, Gai Z, Kullak-Ublick GA, Liu Z. ...
  • Zhu Y, Kang D, Bai X, Luo P, Du B, ...
  • Wang J, Feng Y, Zhang Y, Liu J, Gong L, ...
  • Reddy VKK, Shiddapur G, Jagdale N, Kondapalli MP, Adapa S. ...
  • Hai Y, Lee A, Chen K, Kahaly G. Traditional Chinese ...
  • Zhang Y, Qu Y, Cai R, Gao J, Xu Q, ...
  • Hashemi M, Zandieh MA, Ziaolhagh S, Mojtabavi S, Sadi FH, ...
  • Suzuki T, Yamamoto M. Molecular basis of the Keap۱–Nrf۲ system. ...
  • Zhang J, Zhang M, Tatar M, Gong R. Keap۱-independent Nrf۲ ...
  • Zhang J, Zhao D, Zang Z, Ruan Z, Fu Q, ...
  • Abdelmonem M, Ibrahim SM, Essam RM, Amin HAA, Abd‐Elmawla MA. ...
  • Zhao X-J, Yu H-W, Yang Y-Z, Wu W-Y, Chen T-Y, ...
  • Lianhong X, Weixia S, Wei L, Yanbo L. Diabetic nephropathy ...
  • Sifuentes-Franco S, Padilla-Tejeda DE, Carrillo-Ibarra S, Miranda-Díaz AG. Oxidative stress, ...
  • El Tabaa MM, El Tabaa MM, Rashad E, Elballal MS, ...
  • Unuofin JO, Lebelo SL. Anti-oxidant effects and mechanisms of medicinal ...
  • Shu-Ping L, Yu-Wen W, Sheng-Lan Q, Yun-Peng Z, Deng G, ...
  • نمایش کامل مراجع